(1->4)-beta-D-glucan multiple interactions ISO RGD:1550288 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of F13A1 mRNA CTD PMID:36331819 1-chloro-2,4-dinitrobenzene decreases expression ISO RGD:732286 6480464 Dinitrochlorobenzene results in decreased expression of F13A1 mRNA CTD PMID:17374397 1-naphthyl isothiocyanate affects response to substance ISO RGD:1550288 6480464 F13A1 protein affects the susceptibility to 1-Naphthylisothiocyanate CTD PMID:26921287 17beta-estradiol affects expression ISO RGD:732286 6480464 Estradiol affects the expression of F13A1 mRNA CTD PMID:14699072 17beta-estradiol increases expression ISO RGD:1550288 6480464 Estradiol results in increased expression of F13A1 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO RGD:732286 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of F13A1 mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of F13A1 mRNA CTD PMID:17404688 , PMID:20660070 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550288 6480464 Tetrachlorodibenzodioxin affects the expression of F13A1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of F13A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of F13A1 mRNA CTD PMID:26232522 , PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:732286 6480464 2 more ... CTD PMID:26705709 3,4-methylenedioxymethamphetamine decreases methylation ISO RGD:1550288 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased methylation of F13A1 promoter CTD PMID:26251327 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1550288 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of F13A1 mRNA CTD PMID:26251327 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of F13A1 mRNA CTD PMID:23358152 4,4'-sulfonyldiphenol increases expression ISO RGD:1550288 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of F13A1 mRNA CTD PMID:30951980 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO RGD:732286 6480464 Oxazolone results in decreased expression of F13A1 mRNA CTD PMID:17374397 4-hydroxyphenyl retinamide decreases expression ISO RGD:1550288 6480464 Fenretinide results in decreased expression of F13A1 mRNA CTD PMID:28973697 aflatoxin B1 increases methylation ISO RGD:732286 6480464 Aflatoxin B1 results in increased methylation of F13A1 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:732286 6480464 Tretinoin results in decreased expression of F13A1 mRNA CTD PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of F13A1 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of F13A1 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:732286 6480464 Antirheumatic Agents results in decreased expression of F13A1 mRNA CTD PMID:24449571 arsenous acid increases expression ISO RGD:732286 6480464 Arsenic Trioxide results in increased expression of F13A1 mRNA CTD PMID:20458559 belinostat increases expression ISO RGD:732286 6480464 belinostat results in increased expression of F13A1 mRNA CTD PMID:27188386 benzene decreases expression ISO RGD:732286 6480464 Benzene results in decreased expression of F13A1 mRNA CTD PMID:19162166 benzo[a]pyrene increases expression ISO RGD:1550288 6480464 Benzo(a)pyrene results in increased expression of F13A1 mRNA CTD PMID:32417428 benzo[a]pyrene decreases methylation ISO RGD:1550288 6480464 Benzo(a)pyrene results in decreased methylation of F13A1 intron CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:732286 6480464 Benzo(a)pyrene results in decreased methylation of F13A1 3' UTR, Benzo(a)pyrene results in decreased methylation of F13A1 promoter CTD PMID:27901495 benzo[b]fluoranthene increases expression ISO RGD:1550288 6480464 benzo(b)fluoranthene results in increased expression of F13A1 mRNA CTD PMID:26377693 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of F13A1 mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO RGD:1550288 6480464 bisphenol A results in increased expression of F13A1 mRNA CTD PMID:32156529 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of F13A1 mRNA CTD PMID:33296240 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of F13A1 gene CTD PMID:28505145 bisphenol F increases expression ISO RGD:1550288 6480464 bisphenol F results in increased expression of F13A1 mRNA CTD PMID:30951980 calcitriol decreases expression ISO RGD:732286 6480464 Calcitriol results in decreased expression of F13A1 mRNA CTD PMID:26485663 carbon nanotube increases expression ISO RGD:1550288 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:732286 6480464 CGP 52608 promotes the reaction [RORA protein binds to F13A1 gene] CTD PMID:28238834 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of F13A1 mRNA CTD PMID:23125180 chrysene increases expression ISO RGD:1550288 6480464 chrysene results in increased expression of F13A1 mRNA CTD PMID:26377693 copper atom decreases expression EXP 6480464 Copper results in decreased expression of F13A1 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of F13A1 mRNA CTD PMID:30556269 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of F13A1 mRNA CTD PMID:23640034 dextran sulfate multiple interactions ISO RGD:1550288 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of F13A1 mRNA CTD PMID:29950665 diarsenic trioxide increases expression ISO RGD:732286 6480464 Arsenic Trioxide results in increased expression of F13A1 mRNA CTD PMID:20458559 diclofenac increases expression ISO RGD:1550288 6480464 Diclofenac results in increased expression of F13A1 mRNA CTD PMID:26934552 dioxygen multiple interactions ISO RGD:1550288 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of F13A1 mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of F13A1 mRNA CTD PMID:33729688 diuron decreases expression EXP 6480464 Diuron results in decreased expression of F13A1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:732286 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F13A1 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732286 6480464 Doxorubicin results in decreased expression of F13A1 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of F13A1 mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:1550288 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of F13A1 mRNA CTD PMID:30517762 eugenol decreases expression ISO RGD:732286 6480464 Eugenol results in decreased expression of F13A1 mRNA CTD PMID:17374397 genistein decreases expression ISO RGD:1550288 6480464 Genistein results in decreased expression of F13A1 mRNA CTD PMID:32186404 graphite affects expression EXP 6480464 Graphite affects the expression of F13A1 mRNA CTD PMID:29933104 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of F13A1 mRNA CTD PMID:22129741 inulin multiple interactions ISO RGD:1550288 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of F13A1 mRNA CTD PMID:36331819 iron atom decreases expression ISO RGD:732286 6480464 Iron deficiency results in decreased expression of F13A1 mRNA CTD PMID:20368581 iron(0) decreases expression ISO RGD:732286 6480464 Iron deficiency results in decreased expression of F13A1 mRNA CTD PMID:20368581 isoprenaline increases expression ISO RGD:1550288 6480464 Isoproterenol results in increased expression of F13A1 mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:732286 6480464 Ivermectin results in decreased expression of F13A1 protein CTD PMID:32959892 lead diacetate increases expression ISO RGD:732286 6480464 lead acetate results in increased expression of F13A1 mRNA CTD PMID:27562236 medroxyprogesterone acetate increases expression ISO RGD:732286 6480464 Medroxyprogesterone Acetate results in increased expression of F13A1 mRNA CTD PMID:20843944 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of F13A1 mRNA CTD PMID:23358152 metacetamol decreases expression ISO RGD:1550288 6480464 3-hydroxyacetanilide results in decreased expression of F13A mRNA CTD PMID:18544908 methotrexate decreases expression ISO RGD:732286 6480464 Methotrexate results in decreased expression of F13A1 mRNA CTD PMID:24449571 mifepristone increases expression ISO RGD:732286 6480464 Mifepristone results in increased expression of F13A1 mRNA CTD PMID:17584828 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of F13A1 gene CTD PMID:33148267 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of F13A1 mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of F13A1 mRNA CTD PMID:22129741 nickel sulfate decreases expression ISO RGD:732286 6480464 nickel sulfate results in decreased expression of F13A1 mRNA CTD PMID:16780908 , PMID:17374397 ozone increases expression ISO RGD:1550288 6480464 Ozone results in increased expression of F13A1 mRNA CTD PMID:31626304 ozone multiple interactions ISO RGD:1550288 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of F13A1 mRNA CTD PMID:34911549 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of F13A1 mRNA CTD PMID:18754875 paracetamol affects expression ISO RGD:1550288 6480464 Acetaminophen affects the expression of F13A1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1550288 6480464 Acetaminophen results in increased expression of F13A mRNA CTD PMID:18544908 paraquat multiple interactions ISO RGD:732286 6480464 [Paraquat co-treated with Antigens, Dermatophagoides] results in decreased expression of F13A1 mRNA CTD PMID:34097952 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1550288 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of F13A1 mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of F13A1 mRNA CTD PMID:36331819 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of F13A1 gene CTD PMID:33148267 phenylmercury acetate increases expression ISO RGD:732286 6480464 Phenylmercuric Acetate results in increased expression of F13A1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:732286 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F13A1 mRNA CTD PMID:27188386 pravastatin decreases expression ISO RGD:1550288 6480464 Pravastatin results in decreased expression of F13A1 mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of F13A1 mRNA CTD PMID:27225895 progesterone multiple interactions ISO RGD:732286 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of F13A1 mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of F13A1 mRNA CTD PMID:17404688 , PMID:20660070 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of F13A1 mRNA CTD PMID:23358152 raloxifene affects expression ISO RGD:732286 6480464 Raloxifene Hydrochloride affects the expression of F13A1 mRNA CTD PMID:14699072 resveratrol increases expression ISO RGD:1550288 6480464 resveratrol results in increased expression of F13A1 mRNA CTD PMID:25280562 SB 431542 multiple interactions ISO RGD:732286 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of F13A1 mRNA CTD PMID:27188386 senecionine increases expression ISO RGD:1550288 6480464 senecionine results in increased expression of F13A1 protein CTD PMID:35357534 silicon dioxide increases expression ISO RGD:1550288 6480464 Silicon Dioxide results in increased expression of F13A1 mRNA CTD PMID:23221170 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of F13A1 mRNA CTD PMID:32721576 succimer multiple interactions ISO RGD:732286 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of F13A1 mRNA CTD PMID:26378955 sulforaphane decreases expression ISO RGD:732286 6480464 sulforaphane results in decreased expression of F13A1 mRNA CTD PMID:26833863 tamoxifen affects expression ISO RGD:732286 6480464 Tamoxifen affects the expression of F13A1 mRNA CTD PMID:14699072 tamoxifen multiple interactions ISO RGD:732286 6480464 ESR2 protein affects the reaction [Tamoxifen results in decreased expression of F13A1 mRNA] CTD PMID:14699072 tebuconazole decreases expression ISO RGD:732286 6480464 tebuconazole results in decreased expression of F13A1 mRNA CTD PMID:30458266 tetrachloromethane increases expression ISO RGD:1550288 6480464 Carbon Tetrachloride results in increased expression of F13A1 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane multiple interactions ISO RGD:1550288 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of F13A1 mRNA CTD PMID:30517762 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of F13A1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1550288 6480464 titanium dioxide results in increased expression of F13A1 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:1550288 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of F13A1 mRNA CTD PMID:29950665 tremolite asbestos increases expression ISO RGD:1550288 6480464 tremolite results in increased expression of F13A1 mRNA CTD PMID:29279043 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of F13A1 mRNA CTD PMID:21683754 triptonide increases expression ISO RGD:1550288 6480464 triptonide results in increased expression of F13A1 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1550288 6480464 troglitazone results in increased expression of F13A1 mRNA CTD PMID:28973697 tungsten decreases expression ISO RGD:1550288 6480464 Tungsten results in decreased expression of F13A1 mRNA CTD PMID:30912803 valproic acid decreases expression ISO RGD:732286 6480464 Valproic Acid results in decreased expression of F13A1 protein CTD PMID:12859294 valproic acid affects expression ISO RGD:732286 6480464 Valproic Acid affects the expression of F13A1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:732286 6480464 Valproic Acid results in increased expression of F13A1 mRNA CTD PMID:23179753 vitamin D affects expression ISO RGD:732286 6480464 Vitamin D affects the expression of F13A1 mRNA CTD PMID:20368581 vorinostat increases expression ISO RGD:732286 6480464 vorinostat results in increased expression of F13A1 mRNA CTD PMID:27188386 zaragozic acid A affects expression EXP 6480464 squalestatin 1 affects the expression of F13A1 mRNA CTD PMID:27225895 zaragozic acid A affects expression ISO RGD:1550288 6480464 squalestatin 1 affects the expression of F13A1 mRNA CTD PMID:27225895